Medicine guide
VYNDAQEL
As listed in the register: VYNDAQEL 20 mg, capsule molle
20 mg · capsule molle
- Prescription only
- Active substance
- Tafamidis Méglumine
- Made by
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | PFIZER EUROPE MA EEIG (BELGIQUE) |
|---|---|
| Active substance | Tafamidis Méglumine |
| Strength | 20 mg |
| Form | capsule molle |
| Route | orale |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services NEUROLOGIE · prescription hospitalière · liste I |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/11/717 |
| Name in the register | VYNDAQEL 20 mg, capsule molle |
| Packs | plaquettes PVC polyamide aluminium PVC-Aluminium de 30 x 1 capsules (conditionnement unitaire) |
| CIS | 66376626 |
| CIP13 | 3400921824599 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- capsule molle2 products
- 20 mg
- 61 mg